Akèy › Sistèm Imunitè ak Twoub › Ohio › Cleveland
Etid klinik pou Sistèm Imunitè ak Twoub nan Cleveland, OH
8 etid pou Sistèm Imunitè ak Twoub ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
Abatacept for the Treatment of Giant Cell Arteritis
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Inmagene Site 5, Mayfield Heights · 12 mi lwen
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Ap rekriteFaz 2
- Cleveland Clinic, Cleveland
Etid Sistèm Imunitè ak Twoub nan lòt vil
- Washington, DC13 etid
- New York City, NY12 etid
- Boston, MA10 etid
- Philadelphia, PA10 etid
- Atlanta, GA9 etid
- Portland, OR9 etid
- Houston, TX9 etid
- Chicago, IL8 etid
- Los Angeles, CA8 etid
- Milwaukee, WI6 etid
- Seattle, WA6 etid
- Cedar Rapids, IA6 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè (tout kalite)36 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè Metastatik30 etid
- Kansè ovè30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.